The future of FMT in epidemiology looks promising, with ongoing research exploring its applications beyond CDI. Advances in microbiome science and genomics may lead to more targeted and personalized approaches to FMT. Epidemiologists will continue to play a pivotal role in validating the efficacy and safety of these new interventions and in integrating them into public health strategies.
